Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repros Therapeutics Inc (NASDAQ:RPRX)

7.41
Delayed Data
As of Sep 02
 +0.15 / +2.07%
Today’s Change
5.92
Today|||52-Week Range
22.55
-25.68%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization115.0K145.0K257.0K43.0K
 
 
 
 
 
 
Operating ExpensesGross Income-115.0K-145.0K-257.0K-43.0K
 
 
 
 
 
General Expenses12.4M18.0M27.5M32.5M
 
 
 
 
 
Research And Development8.7M13.3M22.9M27.1M
 
 
 
 
 
Total Operating Expenses12.5M18.2M27.7M32.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.5M-18.2M-27.7M-32.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.5M-18.2M-27.7M-32.5M
 
 
 
 
 
Net Income-12.5M-18.2M-27.7M-32.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.0M15.3M20.8M23.4M
 
 
 
 
 
Shares To Calculate EPS Diluted12.0M15.3M20.8M23.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.04-$1.18-$1.33-$1.39
 
 
 
 
 
EPS Diluted-$1.04-$1.18-$1.33-$1.39